← All stocks

Longeveron Inc.

LGVN Net buying
CIK 0001721484 #4934 in the set updated 22 Sep 2026
Bought (120 mo)
$2.89M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.30M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.30M
17 of 17 sales
Net
+$1.59M
+$1.59M against sales at will

By person

30 insiders · 46 transactions

There is no salary here to measure against. Longeveron Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Soffer Donald M
Director
$1.00M (1)
+$1.00M
21,490,847
$26.86M
−5.0%
Hare Joshua
Chief Scientific Officer
$1.40M (7)
$728.84K (6)
+$675.55K
10,811,369
$13.51M
+12.2%
Clavijo James
CFO and Treasurer
$16.70K (1)
$386.79K (4)
−$370.09K
47,303
$59.13K
−49.5%
Soffer Rock
Director
$398.66K (6)
$182.03K (6)
+$216.64K
964,385
$1.21M
+894.3%
Hashad Mohamed Wa'el Ahmed
Chief Executive Officer
$25.00K (1)
+$25.00K
510,681
$638.35K
+5,588%
PFEFFER JEFFREY
Director
$13.50K (1)
+$13.50K
15,000
$18.75K
Baluch Khoso
Director
$14.26K (3)
$2.59K (1)
+$11.67K
67,391
$84.24K
+4,393%
Ross Cathy
Director
$6.54K (1)
+$6.54K
10,000
$12.50K
Lehr Paul T
General Counsel, Secretary
$5.85K (1)
+$5.85K
1,003,829
$1.25M
+521.8%
Green Geoff
CEO
$3.81K (1)
+$3.81K
133,904
$167.38K
−23.2%
Locklear Lisa
Chief Financial Officer
(1)
$0.00
480,005
$600.01K
+12,933%
Willard Stephen H
Chief Executive Officer
771,681
$964.60K
Agafonova Nataliya
Chief Medical Officer
737,700
$922.13K
+35,383%
Blass Devin
CTO & SVP of CMC
711,735
$889.67K
+487.8%
Jhaveri Nirav S.
Chief Financial Officer
300,000
$375.00K
Min Kwan-Hong Christopher
Chief Medical Officer
152,335
$190.42K
Powell James Nathaniel
Chief Executive Officer
125,593
$156.99K
+56.1%
Hare Neil E
Director
88,760
$110.95K
+47.3%
Ungaro Ursula
Director
82,000
$102.50K
+16,300%
Paletta George A. Jr.
Director
70,000
$87.50K
Hajjar Roger Joseph
Director
69,000
$86.25K
Desai Arjun JJ
Director
36,000
$45.00K
Cann Leah Rush
Director
36,000
$45.00K
Ascheim Deborah
Director
36,000
$45.00K
Kender Richard N
Director
33,000
$41.25K
Motwani Neha J.
Director
33,000
$41.25K
Borger Erin
Director
22,836
$28.55K
0.0%
Girolamo Todd C
Director
5,000
$6.25K
LOSORDO DOUGLAS W
Director
5,000
$6.25K
DS MED LLC entity
10% owner
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 1,651.0 over the window, from 15,013,072 to 24,786,282,000 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Baluch Khoso
11 Aug 2025
Director
Buy
11,766
no price
Locklear Lisa
11 Aug 2025
Chief Financial Officer
Buy
11,766
no price
Soffer Rock
30 May 2025
Director
Sell
11,000
$1.25
$13.75K
Soffer Rock
29 May 2025
Director
Sell
10,000
$1.30
$13.00K
Soffer Rock
22 May 2025
Director
Sell
2,000
$1.32
$2.64K
Hare Joshua
16 May 2025
Chief Scientific Officer
Sell
5,250
$1.40
$7.37K
Baluch Khoso
2 Dec 2024
Director
Sell
1,250
$2.07
$2.59K
Soffer Rock
11 Apr 2024
Director
Buy
31,915
$2.35
$75.00K
Hashad Mohamed Wa'el Ahmed
11 Apr 2024
Chief Executive Officer
Buy
10,638
$2.35
$25.00K
Hare Joshua
11 Apr 2024
Chief Scientific Officer
Buy
42,553
$2.35
$100.00K
Soffer Rock
10 Apr 2024
Director
Buy
106,383
$2.35
$250.00K
Hare Joshua
10 Apr 2024
Chief Scientific Officer
Buy
106,383
$2.35
$250.00K
Ross Cathy
10 Jan 2024
Director
Buy
5,000
$1.31
$6.54K
Baluch Khoso
29 Dec 2023
Director
Buy
8,322
$1.43
$11.91K
PFEFFER JEFFREY
28 Dec 2023
Director
Buy
10,000
$1.35
$13.50K
Baluch Khoso
28 Dec 2023
Director
Buy
1,678
$1.40
$2.34K
Hare Joshua
21 Sep 2023
Chief Scientific Officer
Exercised, kept
5,000
$3.00
$15.00K
Lehr Paul T
20 Sep 2023
General Counsel, Secretary
Exercised, kept
2,000
$3.00
$6.00K
Hashad Mohamed Wa'el Ahmed
12 Sep 2023
Chief Executive Officer
Exercised, kept
10,000
$3.00
$30.00K
Hare Joshua
12 Sep 2023
Chief Scientific Officer
Exercised, kept
30,000
$3.00
$90.00K
Soffer Rock
8 Sep 2023
Director
Exercised, kept
30,000
$3.00
$90.00K
Clavijo James
29 Jun 2023
CFO and Treasurer
Sell
5,000
$3.51
$17.55K
Clavijo James
28 Jun 2023
CFO and Treasurer
Sell
10,000
$3.43
$34.30K
Clavijo James
27 Jun 2023
CFO and Treasurer
Sell
8,532
$3.48
$29.69K
Hare Joshua
27 Jan 2023
Chief Scientific Officer
Sell
20,000
$4.28
$85.60K
Hare Joshua
2 Dec 2022
Chief Scientific Officer
Sell
20,000
$3.74
$74.80K
Hare Joshua
12 Oct 2022
Chief Scientific Officer
Sell
100,000
$3.61
$361.00K
Clavijo James
3 Jun 2022
CFO and Treasurer
Sell
36,955
$8.26
$305.25K
Soffer Rock
24 May 2022
Director
Sell
4,000
$7.50
$30.00K
Soffer Rock
23 May 2022
Director
Sell
8,000
$7.78
$62.20K
Soffer Rock
20 May 2022
Director
Sell
7,500
$8.06
$60.44K
Hare Joshua
19 Apr 2022
Chief Scientific Officer
Sell
78
$10.00
$780.00
Hare Joshua
18 Apr 2022
Chief Scientific Officer
Sell
19,922
$10.00
$199.29K
Soffer Rock
13 Oct 2021
Director
Buy
12,000
$3.76
$45.12K
Green Geoff
13 Oct 2021
CEO
Buy
1,000
$3.81
$3.81K
Soffer Rock
12 Oct 2021
Director
Buy
4,000
$3.57
$14.28K
Hare Joshua
12 Oct 2021
Chief Scientific Officer
Buy
2,500
$3.69
$9.23K
Soffer Rock
11 Oct 2021
Director
Buy
3,900
$3.45
$13.46K
Hare Joshua
8 Oct 2021
Chief Scientific Officer
Buy
3,015
$3.39
$10.22K
Hare Joshua
7 Oct 2021
Chief Scientific Officer
Buy
1,985
$3.38
$6.71K
Lehr Paul T
7 Oct 2021
General Counsel, Secretary
Buy
1,750
$3.34
$5.85K
Clavijo James
7 Oct 2021
CFO and Treasurer
Buy
5,000
$3.34
$16.70K
Hare Joshua
12 Feb 2021
Chief Scientific Officer
Buy
1,000
$8.23
$8.23K
Hare Joshua
12 Feb 2021
Chief Scientific Officer
Buy
102,000
$10.00
$1.02M
Soffer Donald M
12 Feb 2021
Director
Buy
100,000
$10.00
$1.00M
Soffer Rock
12 Feb 2021
Director
Buy
100
$8.05
$805.00

What was left out

Form 4 filings counted 206
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 17
Transactions with no price 2
Shares from compensation/vesting 30,382,881
Sales filed before the plan box existed 9
History held since 17 Feb 2021